Share
6,251 Posts.
lightbulb Created with Sketch. 1198
clock Created with Sketch. 22/03/23
16:49
Share
Originally posted by Shellbell
↑
Do you think its safe to assume that the future landscape of PTX will reflect Kerry Stevenson's sumation that our CEO is a "trustworthy custodian of the PTX treasury"? Based on the scenarios of two different approaches to getting a potential drug through to commercialisation as illustrated by Hottod and Dalts on ther other thread, plus the cost per patient that SYC mentioned in that interview with KS, I believe that the most prudent approach that SYC is likely to take is to find a partner. more milestone "payments" by way of shares could be owing to the original owner of the drug, namely Pathway Oncology Pty Ltd. Its likely that advancing PTX100 to a Phase 2 / registrational trial will have a milestone payment attached. I can't say for sure based on some superficial fossicking.
Expand
The issue is, the value discount to sell off an interest now is so huge that it may not be worth the effort. Try building half a boat and selling it on Ebay. You'd be lucky to get your costs recovered.
